Cargando…

Bayesian analysis of baseline risk of CIN2 and ≥CIN3 by HPV genotype in a European referral cohort

Whereas HPV16 and HPV18 have been the focus in current risk‐based cervical cancer screening algorithms using HPV genotype information, mounting evidence suggests that oncogenic HPV types such as HPV31, 33, 52 and 58 pose a ≥CIN3 risk equivalent to or greater than that of HPV18, and the combined risk...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bonde, Jesper, Bottari, Fabio, Parvu, Valentin, Pedersen, Helle, Yanson, Karen, Iacobone, Anna D., Kodsi, Salma, Landoni, Fabio, Vaughan, Laurence, Ejegod, Ditte M., Sandri, Maria T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2019
Materias:	Infectious Causes of Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617734/ https://www.ncbi.nlm.nih.gov/pubmed/30895602 http://dx.doi.org/10.1002/ijc.32291

Ejemplares similares

Evaluating HPV‐negative CIN2+ in the ATHENA trial
por: Petry, Karl Ulrich, et al.
Publicado: (2016)

Clinical and analytical performance of the BD Onclarity™ HPV assay for detection of CIN2+ lesions on SurePath samples
por: Ejegod, Ditte Møller, et al.
Publicado: (2016)

The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening
por: Ejegod, Ditte, et al.
Publicado: (2016)

HPV Tests Comparison in the Detection and Follow-Up after Surgical Treatment of CIN2+ Lesions
por: Bottari, Fabio, et al.
Publicado: (2022)

HPV-Testing in Follow-up of Patients Treated for CIN2+ Lesions
por: Mariani, Luciano, et al.
Publicado: (2016)

Progression of CIN1/LSIL HPV Persistent of the Cervix: Actual Progression or CIN3 Coexistence
por: Bruno, Maria Teresa, et al.
Publicado: (2021)

Dysregulation of host cellular genes targeted by human papillomavirus (HPV) integration contributes to HPV‐related cervical carcinogenesis
por: Zhang, Ruiyang, et al.
Publicado: (2016)

Potential effectiveness of a therapeutic HPV intervention campaign in Uganda
por: Spencer, Jennifer C., et al.
Publicado: (2021)

Short half‐life of HPV16 E6 and E7 mRNAs sensitizes HPV16‐positive tonsillar cancer cell line HN26 to DNA‐damaging drugs
por: Wu, Chengjun, et al.
Publicado: (2018)

HPV Testing With 16, 18, and 45 Genotyping Stratifies Cancer Risk for Women With Normal Cytology: Data From the Baseline Phase of the Onclarity Trial
por: Stoler, Mark H, et al.
Publicado: (2019)

The wages of CIN
por: Yuen, Karen W., et al.
Publicado: (2008)

Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study
por: Rachel Skinner, S., et al.
Publicado: (2016)

Baseline prevalence and type distribution of human papillomavirus in healthy Chinese women aged 18–25 years enrolled in a clinical trial
por: Zhao, Fang-Hui, et al.
Publicado: (2014)

Assessment of herd effects among women and heterosexual men after girls‐only HPV16/18 vaccination in the Netherlands: A repeated cross‐sectional study
por: Woestenberg, Petra J, et al.
Publicado: (2018)

Human Papillomavirus Same Genotype Persistence and Risk: A Systematic Review
por: Bonde, Jesper, et al.
Publicado: (2020)

Efficacy, immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese women aged 18–25 years: Results from a randomized controlled trial
por: Zhu, Feng-Cai, et al.
Publicado: (2014)

Time and temperature dependent analytical stability of dry-collected Evalyn HPV self-sampling brush for cervical cancer screening
por: Ejegod, Ditte Møller, et al.
Publicado: (2018)

Tincture Cin Honœ Ferrata
por: Sims, Samuel
Publicado: (1853)

Comparison of analytical and clinical performance of CLART HPV2 genotyping assay to Linear Array and Hybrid Capture 2: a split-sample study
por: Ejegod, Ditte Møller, et al.
Publicado: (2015)

Therapeutic vaccination using HPV 16 E7 to eradicate CIN3
por: Tewari, Krishnansu S.
Publicado: (2019)

A new assay for measuring chromosome instability (CIN) and identification of drugs that elevate CIN in cancer cells
por: Lee, Hee-Sheung, et al.
Publicado: (2013)

Are CIN3 risk or CIN3+ risk measures reliable surrogates for invasive cervical cancer risk?
por: Austin, R. Marshall, et al.
Publicado: (2020)

Efficacy and safety of therapeutic HPV vaccines to treat CIN 2/CIN 3 lesions: a systematic review and meta-analysis of phase II/III clinical trials
por: Ibrahim Khalil, Ahmadaye, et al.
Publicado: (2023)

Reliable identification of women with CIN3+ using hrHPV genotyping and methylation markers in a cytology‐screened referral population
por: Leeman, Annemiek, et al.
Publicado: (2018)

Quantitative Histopathological Analysis of CIN Sections
por: Baak, Jan P. A.
Publicado: (2006)

Quantitative Histopathological Analysis of CIN Sections
por: Guillaud, Martial, et al.
Publicado: (2006)

Evolution of aneuploidy: overcoming the original CIN
por: Storchova, Zuzana
Publicado: (2018)

Up to your NEK2 in CIN
por: Seachrist, Darcie D., et al.
Publicado: (2021)

The adaptive strategies of cells in the face of CIN
por: Storchová, Zuzana
Publicado: (2023)

Clinical and Analytical Performance of the BD Onclarity HPV Assay with SurePath Screening Samples from the Danish Cervical Screening Program Using the VALGENT Framework
por: Bonde, Jesper Hansen, et al.
Publicado: (2020)

HPV58 E7 Protein Expression Profile in Cervical Cancer and CIN with Immunohistochemistry
por: Zheng, Qiaoli, et al.
Publicado: (2021)

Overexpression of programmed cell death ligand 1 in patients with CIN and its correlation with human papillomavirus infection and CIN persistence
por: Sancakli Usta, Ceyda, et al.
Publicado: (2020)

E6/E7 mRNA testing for human papilloma virus-induced high-grade cervical intraepithelial disease (CIN2/CIN3): a promising perspective
por: Origoni, Massimo, et al.
Publicado: (2015)

The influence of type-specific human papillomavirus infections on the detection of cervical precancer and cancer: A population-based study of opportunistic cervical screening in the United States
por: Wheeler, Cosette M, et al.
Publicado: (2014)

Trends in Kaposi's sarcoma-associated Herpesvirus antibodies prior to the development of HIV-associated Kaposi's sarcoma: A nested case-control study
por: Wakeham, Katie, et al.
Publicado: (2015)

Comprehensive metagenomic analysis of glioblastoma reveals absence of known virus despite antiviral-like type I interferon gene response
por: Cosset, Érika, et al.
Publicado: (2014)

Human papillomavirus prevalence and type‐distribution in cervical glandular neoplasias: Results from a European multinational epidemiological study
por: Holl, Katsiaryna, et al.
Publicado: (2015)

A bacterial genotoxin causes virus reactivation and genomic instability in Epstein–Barr virus infected epithelial cells pointing to a role of co‐infection in viral oncogenesis
por: Frisan, Teresa, et al.
Publicado: (2018)

Cause‐specific mortality after diagnosis of cancer among HIV‐positive patients: A collaborative analysis of cohort studies
por: Trickey, Adam, et al.
Publicado: (2020)

Cutaneous viral infections associated with ultraviolet radiation exposure
por: Zhao, Yayi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2q6u8u9ek4hcilq1lr5bukhc2e